Boston Scientific Corporation Stock Mexican S.E.
Stocks
BSX *
US1011371077
Advanced Medical Equipment & Technology
|
End-of-day quote
Mexican S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 747.34 MXN | +0.05% |
|
+2.59% | -56.55% |
| 09-17 | Boston Scientific Shares Fall After Citigroup Downgrade | MT |
| 09-17 | Citigroup Downgrades Boston Scientific to Neutral From Buy, Adjusts PT to $50 From $57 | MT |
| Market Cap | 62.81B 1,084B 54.77B 51.72B 46.96B 87.99B 6,027B 88.35B 619B 239B 3,064B 236B 231B 9,859B | P/E 2026 * |
16.4x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 71.54B 1,235B 62.38B 58.9B 53.49B 100B 6,864B 101B 706B 272B 3,490B 269B 263B 11,229B | EV / Sales 2026 * |
3.36x | EV / Sales 2027 * | 3.06x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
London S.E.
| 0HOY | Delayed | |
|
Tradegate
| BSX | Real-time | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.05% | ||
| 1 week | +2.59% | ||
| Current month | -8.73% | ||
| 1 month | -15.36% | ||
| 3 months | -5.61% | ||
| 6 months | -40.69% | ||
| Current year | -56.55% |
| 1 week | 741 |  | 771.45 |
| 1 month | 728 | | 854.99 |
| Current year | 728 | | 1,792.52 |
| 1 year | 728 | | 1,945.17 |
| 3 years | 728 | | 2,205.63 |
| 5 years | 728 | | 2,205.63 |
| 10 years | 650.5 | | 2,205.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.05% | +2.59% | - | - | 62.81B | |
| -1.04% | +6.83% | +35.84% | +28.05% | 241B | |
| -0.32% | +5.83% | +9.58% | -17.01% | 149B | |
| +2.55% | +6.55% | -10.35% | +31.26% | 139B | |
| -0.48% | +0.84% | -55.70% | -18.27% | 62.81B | |
| +0.01% | +4.61% | +18.61% | +20.87% | 50.87B | |
| -1.69% | -1.20% | -19.89% | -15.39% | 48.21B | |
| +0.08% | +6.49% | +23.87% | +39.32% | 44.11B | |
| -1.88% | +3.25% | +40.14% | +53.16% | 41.42B | |
| -2.27% | +16.07% | +133.21% | +70.51% | 36.18B | |
| Average | -0.50% | +6.42% | +19.48% | +21.39% | 90.26B | |
| Weighted average by Cap. | -0.24% | +6.14% | +15.57% | +17.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.31B 368B 18.58B 17.55B 15.93B 29.85B 2,045B 29.98B 210B 81.11B 1,040B 80.06B 78.28B 3,345B | 22.29B 385B 19.44B 18.35B 16.67B 31.22B 2,139B 31.35B 220B 84.83B 1,087B 83.73B 81.87B 3,499B |
| Net income | 3.8B 65.53B 3.31B 3.13B 2.84B 5.32B 364B 5.34B 37.44B 14.45B 185B 14.26B 13.94B 596B | 3.68B 63.54B 3.21B 3.03B 2.75B 5.16B 353B 5.18B 36.3B 14.01B 180B 13.83B 13.52B 578B |
| Net Debt | 8.73B 151B 7.61B 7.19B 6.52B 12.22B 837B 12.28B 86.07B 33.21B 426B 32.78B 32.05B 1,370B | 5.47B 94.46B 4.77B 4.51B 4.09B 7.66B 525B 7.7B 53.96B 20.82B 267B 20.55B 20.1B 859B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | MX$747.34 | +0.05% | 131 |
| 17/09/26 | MX$747.00 | -1.71% | 453 |
| 15/09/26 | MX$760.00 | -1.48% | 440 |
| 14/09/26 | MX$771.45 | +5.90% | 246 |
| 11/09/26 | MX$728.50 | -0.64% | 59 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
- BSX * Stock
Select your edition
All financial news and data tailored to specific country editions
